Growth Metrics

Catalyst Pharmaceuticals (CPRX) EBT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.59%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -313.33%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 71.54%
7 Evaxion A 62.56 Bn 62.54 Bn - -79.57%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 9,460.35%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 18.16%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 18.16%
Dec 31, 2025 -3.07%
Sep 30, 2025 24.18%
Jun 30, 2025 24.21%
Mar 31, 2025 145.06%
Dec 31, 2024 58.82%
Sep 30, 2024 250.46%
Jun 30, 2024 15.00%
Mar 31, 2024 -22.04%
Dec 31, 2023 41.50%
Sep 30, 2023 -246.20%
Jun 30, 2023 71.75%
Mar 31, 2023 113.72%
Dec 31, 2022 157.61%
Sep 30, 2022 84.81%
Jun 30, 2022 77.64%
Mar 31, 2022 76.67%
Dec 31, 2021 46.87%
Sep 30, 2021 19.89%
Jun 30, 2021 52.99%
Mar 31, 2021 -10.46%
Dec 31, 2020 3.79%
Sep 30, 2020 -17.57%
Jun 30, 2020 -8.91%
Mar 31, 2020 1,812.33%
Dec 31, 2019 157.97%
Sep 30, 2019 281.64%
Jun 30, 2019 291.27%
Mar 31, 2019 88.69%
Dec 31, 2018 -169.12%
Sep 30, 2018 -87.64%
Jun 30, 2018 -53.74%
Mar 31, 2018 -14.75%
Dec 31, 2017 -29.41%
Sep 30, 2017 -5.66%
Jun 30, 2017 15.08%
Mar 31, 2017 7.78%
Dec 31, 2016 28.41%
Sep 30, 2016 11.13%
Jun 30, 2016 -0.23%
Mar 31, 2016 0.44%
Dec 31, 2015 -66.62%
Sep 30, 2015 11.19%
Jun 30, 2015 -42.54%
Mar 31, 2015 -41.96%
Dec 31, 2014 -157.63%
Sep 30, 2014 15.26%
Jun 30, 2014 -1.73%
Mar 31, 2014 -118.49%
Dec 31, 2013 -1,668.83%
Sep 30, 2013 -125.52%
Jun 30, 2013 -987.45%
Mar 31, 2013 -60.15%
Dec 31, 2012 96.74%
Sep 30, 2012 -132.44%
Jun 30, 2012 79.26%
Mar 31, 2012 28.21%
Dec 31, 2011 -222.73%
Sep 30, 2011 -24.76%